已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Increasing Age and Survival after Orthotopic Liver Transplantation for Patients with Hepatocellular Cancer

医学 肝细胞癌 内科学 肝移植 多元分析 糖尿病 肝癌 存活率 肝病 癌症 丙型肝炎 移植 单变量分析 外科 胃肠病学 内分泌学
作者
Joseph Kim,Michelle E. Ko,Rebecca A. Nelson,Amanda K. Arrington,Carrie Luu,Ann E. Falor,Nicholas N. Nissen,Steven D. Colquhoun,Arti Hurria,Gagandeep Singh
出处
期刊:Journal of The American College of Surgeons [Lippincott Williams & Wilkins]
卷期号:218 (3): 431-438 被引量:22
标识
DOI:10.1016/j.jamcollsurg.2013.12.001
摘要

Orthotopic liver transplantation (OLT) is the gold standard treatment for patients with early hepatocellular carcinoma (HCC). There are concerns about the efficacy of OLT for HCC in older patients, who we hypothesized might have poorer outcomes. Therefore, we sought to examine advanced age and its impact on OLT outcomes.The United Network for Organ Sharing database was queried for patients who underwent OLT for HCC from 1987 to 2009. Patients were divided into 3 age groups: 35 to 49 years old, 50 to 64 years old, and 65 years or older, and patient characteristics were compared. Univariate and multivariate analyses were performed to assess the impact of age on OLT outcomes.Of 10,238 patients with OLT for HCC, 16.5% (n = 1,688) of patients were 35 to 49 years old, 67.8% (n = 6,937) were 35 to 49 years old, and 15.8% (n = 1,613) were 65 years and older. By Kaplan-Meier method, the 50- to 64-year-old age group had the highest overall survival, despite having one of the highest rates of hepatitis C positivity (70%), but this group also had the lowest rate of diabetes mellitus (8.7%). The lowest overall survival was observed in the 65-year or older age group (p < 0.001). Finally, there was no difference in disease-specific survival among the age groups (p = 0.858), and patients aged 65 years and older had the highest rate of death from nonhepatic causes (17.5%).Although OS was prolonged in younger patients who underwent OLT for HCC, there was no observed difference in disease-specific survival among the age groups. Our results suggest that carefully selected patients 65 years of age and older can derive equal benefit from OLT for HCC when compared with their younger counterparts.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
鲤鱼初柳完成签到 ,获得积分10
1秒前
2秒前
2秒前
GPTea的应助被高冷汉堡包采纳,获得20
4秒前
4秒前
5秒前
111发布了新的文献求助10
5秒前
ljz发布了新的文献求助10
5秒前
zfj完成签到 ,获得积分10
6秒前
聪明海云完成签到,获得积分20
7秒前
机灵猕猴桃完成签到,获得积分10
7秒前
科研通AI6.4的应助被Qiqi采纳,获得10
7秒前
MoeBella发布了新的文献求助10
7秒前
8秒前
阿南发布了新的文献求助10
9秒前
flora发布了新的文献求助10
10秒前
yoonkk完成签到,获得积分10
11秒前
李爱国的应助被林夏采纳,获得10
11秒前
11秒前
传奇3的应助被academician采纳,获得10
13秒前
共享精神的应助被chengqian采纳,获得10
13秒前
15秒前
Yl完成签到 ,获得积分10
15秒前
小蘑菇的应助被xc采纳,获得10
16秒前
SpaceThing发布了新的文献求助10
17秒前
无名小羊完成签到 ,获得积分10
19秒前
19秒前
19秒前
19秒前
ASIMISMO完成签到,获得积分10
19秒前
葛煜完成签到 ,获得积分10
21秒前
852的应助被原神大王采纳,获得10
22秒前
22秒前
23秒前
彩色的迎梦完成签到,获得积分10
23秒前
SaSS发布了新的文献求助10
24秒前
ljz完成签到 ,获得积分20
24秒前
xiaoxu发布了新的文献求助10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189694
求助须知:如何正确求助?哪些是违规求助? 9576952
关于积分的说明 21850481
捐赠科研通 7787646
什么是DOI,文献DOI怎么找? 3435759
关于科研通互助平台的介绍 2559813
邀请新用户注册赠送积分活动 2482624